Supplementary Table S2 from Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
Matthew Clarke(University of Aberdeen), Tobey J. MacDonald(Children's National), Iris Stoler(Humboldt-Universität zu Berlin), Kelly Haupfear(St. Jude Children's Research Hospital), Alex Virasami(Great Ormond Street Hospital), Louise Howell(Institute of Cancer Research), Jessica K.R. Boult(Institute of Cancer Research), Safa Al‐Sarraj(King's College Hospital), Paula Proszek(BMW (Germany)), Jane Chalker(Great Ormond Street Hospital), Tejus Bale(Memorial Sloan Kettering Cancer Center), David E. Kram(Wake Forest University), Amy R. Fairchild(Great Ormond Street Hospital), Andrew Martin(Clinica Universidad de Navarra), Aimee Avery(Great Ormond Street Hospital), Bassel Zebian(King's College London), Lawrence J. Doey(King's College - North Carolina), Michael Hubank(Royal Marsden Hospital), Valeria Molinari(Institute of Cancer Research), Jessica C. Pickles(Great Ormond Street Hospital), Scott Newman(Guardant (United States)), Elisa Izquierdo(Institute of Cancer Research), Jeffrey Knipstein(Medical College of Wisconsin), Claire Cairns(King's College - North Carolina), Sara Temelso(Institute of Cancer Research), Wilda Orisme(St. Jude Children's Research Hospital), Rachael Natrajan(Institute of Cancer Research), Uwe Kordes(Universität Hamburg), Stephen W. Gilheeney(Memorial Sloan Kettering Cancer Center), Marc K. Rosenblum(Memorial Sloan Kettering Cancer Center), Ira J. Dunkel(Memorial Sloan Kettering Cancer Center), Ulrich Schüller(Universität Hamburg), Ruth Tatevossian(St. Jude Children's Research Hospital), Anna Burford(Cancer Research Institute of the Slovak Academy of Sciences), Alan Mackay(Institute of Cancer Research), Diana Carvalho(Institute of Cancer Research), Kathreena M. Kurian(North Bristol NHS Trust), Debbie Hughes, Matija Snuderl, Catherine Rowe(University of Bristol), Martin Sill(German Cancer Research Center), Britta Ismer(German Cancer Research Center), Simon P. Robinson(Institute of Cancer Research), James Dalton, Ji Wen, Mark Kristiansen(Great Ormond Street Hospital), Leslie Bridges(St George's Hospital), Stephen Crosier(Newcastle upon Tyne Hospitals NHS Foundation Trust), Christopher Chandler(University Hospitals Sussex NHS Foundation Trust), Mellissa Maybury(The University of Queensland)
Cited by 0